These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 29764680)
1. The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4 Jain S; George PJ; Deng W; Koussa J; Parkhouse K; Hensley SE; Jiang J; Lu J; Liu Z; Wei J; Zhan B; Bottazzi ME; Shen H; Lustigman S Vaccine; 2018 Jun; 36(25):3650-3665. PubMed ID: 29764680 [TBL] [Abstract][Full Text] [Related]
2. The Th1/Tfh-like biased responses elicited by the rASP-1 innate adjuvant are dependent on TRIF and Type I IFN receptor pathways. George PJ; Marches R; Nehar-Belaid D; Banchereau J; Lustigman S Front Immunol; 2022; 13():961094. PubMed ID: 36119026 [No Abstract] [Full Text] [Related]
3. LTA1 is a safe, intranasal enterotoxin-based adjuvant that improves vaccine protection against influenza in young, old and B-cell-depleted (μMT) mice. Valli E; Harriett AJ; Nowakowska MK; Baudier RL; Provosty WB; McSween Z; Lawson LB; Nakanishi Y; Norton EB Sci Rep; 2019 Oct; 9(1):15128. PubMed ID: 31641151 [TBL] [Abstract][Full Text] [Related]
4. The cationic liposome CCS/C adjuvant induces immunity to influenza independently of the adaptor protein MyD88. Even-Or O; Avniel-Polak S; Barenholz Y; Nussbaum G Hum Vaccin Immunother; 2020 Dec; 16(12):3146-3154. PubMed ID: 32401698 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant effects of killed Lactobacillus casei DK128 on enhancing T helper type 1 immune responses and the efficacy of influenza vaccination in normal and CD4-deficient mice. Jung YJ; Kim KH; Ko EJ; Lee Y; Kim MC; Lee YT; Kim CH; Jeeva S; Park BR; Kang SM Vaccine; 2020 Aug; 38(36):5783-5792. PubMed ID: 32674907 [TBL] [Abstract][Full Text] [Related]
7. Immunological dynamics after subcutaneous immunization with a squalene-based oil-in-water adjuvant. Schetters STT; Kruijssen LJW; Crommentuijn MHW; Kalay H; den Haan JMM; van Kooyk Y FASEB J; 2020 Sep; 34(9):12406-12418. PubMed ID: 33411367 [TBL] [Abstract][Full Text] [Related]
8. Vaccine efficacy and T helper cell differentiation change with aging. Lefebvre JS; Lorenzo EC; Masters AR; Hopkins JW; Eaton SM; Smiley ST; Haynes L Oncotarget; 2016 Jun; 7(23):33581-94. PubMed ID: 27177221 [TBL] [Abstract][Full Text] [Related]
9. Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice. Cummins NW; Weaver EA; May SM; Croatt AJ; Foreman O; Kennedy RB; Poland GA; Barry MA; Nath KA; Badley AD FASEB J; 2012 Jul; 26(7):2911-8. PubMed ID: 22490782 [TBL] [Abstract][Full Text] [Related]
10. Functional and epigenetic changes in monocytes from adults immunized with an AS01-adjuvanted vaccine. Bechtold V; Smolen KK; Burny W; de Angelis SP; Delandre S; Essaghir A; Marchant A; Ndour C; Taton M; van der Most R; Willems F; Didierlaurent AM Sci Transl Med; 2024 Jul; 16(758):eadl3381. PubMed ID: 39083587 [TBL] [Abstract][Full Text] [Related]
11. Lower influenza-specific cell-mediated immune responses in individuals with atopic dermatitis compared with healthy controls. Jalbert E; Lussier S; Johnson MJ; Jepson B; Calatroni A; David G; Leung D; Weinberg A Hum Vaccin Immunother; 2020 Nov; 16(11):2727-2735. PubMed ID: 32347777 [TBL] [Abstract][Full Text] [Related]
12. Immune senescence in old and very old rhesus monkeys: reduced antibody response to influenza vaccination. Coe CL; Lubach GR; Kinnard J Age (Dordr); 2012 Oct; 34(5):1169-77. PubMed ID: 22231440 [TBL] [Abstract][Full Text] [Related]
16. Altered T cell infiltration and enrichment of leukocyte regulating pathways within aged skeletal muscle are associated impaired muscle function following influenza infection. Keilich SR; Cadar AN; Ahern DT; Torrance BL; Lorenzo EC; Martin DE; Haynes L; Bartley JM Geroscience; 2023 Apr; 45(2):1197-1213. PubMed ID: 36580167 [TBL] [Abstract][Full Text] [Related]
17. Sex Differences in the Blood Transcriptome Identify Robust Changes in Immune Cell Proportions with Aging and Influenza Infection. Bongen E; Lucian H; Khatri A; Fragiadakis GK; Bjornson ZB; Nolan GP; Utz PJ; Khatri P Cell Rep; 2019 Nov; 29(7):1961-1973.e4. PubMed ID: 31722210 [TBL] [Abstract][Full Text] [Related]
18. Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation. Schijns V; Majhen D; van der Ley P; Thakur A; Summerfield A; Berisio R; Nativi C; Fernández-Tejada A; Alvarez-Dominguez C; Gizurarson S; Zamyatina A; Molinaro A; Rosano C; Jakopin Ž; Gursel I; McClean S Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33917629 [TBL] [Abstract][Full Text] [Related]
19. A Pragmatic Guide to Assessing Real Option Value for Medical Technologies. Li M; Garrison L; Lee W; Kowal S; Wong W; Veenstra D Value Health; 2022 Jun; ():. PubMed ID: 35752536 [TBL] [Abstract][Full Text] [Related]
20. Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections. Koger-Pease C; Perera DJ; Ndao M Pharmaceuticals (Basel); 2023 Feb; 16(3):. PubMed ID: 36986434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]